Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Novel targets with potential therapeutic applications in osteosarcoma.

Khanna C.

Curr Oncol Rep. 2008 Jul;10(4):350-8. Review.

PMID:
18778562
2.

Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.

Bacci G, Briccoli A, Ferrari S, Saeter G, Donati D, Longhi A, Manfrini M, Bertoni F, Rimondini S, Monti C, Forni C.

Oncol Rep. 2000 Mar-Apr;7(2):339-46.

PMID:
10671683
3.

New targets and approaches in osteosarcoma.

Gill J, Ahluwalia MK, Geller D, Gorlick R.

Pharmacol Ther. 2013 Jan;137(1):89-99. doi: 10.1016/j.pharmthera.2012.09.003. Epub 2012 Sep 14. Review.

PMID:
22983152
4.

Delaying surgery with chemotherapy for osteosarcoma of the extremities.

Bielack SS, Machatschek JN, Flege S, Jürgens H.

Expert Opin Pharmacother. 2004 Jun;5(6):1243-56. Review.

PMID:
15163270
5.

Toward a drug development path that targets metastatic progression in osteosarcoma.

Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, Weigel B, Randall L, Withrow SJ, Paoloni M, Kaplan R, Teicher BA, Seibel NL, Smith M, Uren A, Patel SR, Trent J, Savage SA, Mirabello L, Reinke D, Barkaukas DA, Krailo M, Bernstein M.

Clin Cancer Res. 2014 Aug 15;20(16):4200-9. doi: 10.1158/1078-0432.CCR-13-2574. Epub 2014 May 6.

6.

High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions.

Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, Forni C, Briccoli A.

J Surg Oncol. 2008 Nov 1;98(6):415-20. doi: 10.1002/jso.21140.

PMID:
18792969
7.

Palliative therapy for osteosarcoma.

Errani C, Longhi A, Rossi G, Rimondi E, Biazzo A, Toscano A, Alì N, Ruggieri P, Alberghini M, Picci P, Bacci G, Mercuri M.

Expert Rev Anticancer Ther. 2011 Feb;11(2):217-27. doi: 10.1586/era.10.172. Review.

PMID:
21342041
8.

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.

Lamora A, Mullard M, Amiaud J, Brion R, Heymann D, Redini F, Verrecchia F.

Oncotarget. 2015 Jun 10;6(16):14413-27.

9.

Bone metastases from osteosarcoma.

San-Julian M, Diaz-de-Rada P, Noain E, Sierrasesumaga L.

Int Orthop. 2003;27(2):117-20. Epub 2002 Oct 12.

PMID:
12700938
10.

Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma.

Shaikh AB, Li F, Li M, He B, He X, Chen G, Guo B, Li D, Jiang F, Dang L, Zheng S, Liang C, Liu J, Lu C, Liu B, Lu J, Wang L, Lu A, Zhang G.

Int J Mol Sci. 2016 Apr 6;17(4):506. doi: 10.3390/ijms17040506. Review.

11.

Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma.

Li CJ, Liu XZ, Zhang L, Chen LB, Shi X, Wu SJ, Zhao JN.

Orthop Surg. 2016 May;8(2):105-10. doi: 10.1111/os.12238. Review.

PMID:
27384718
12.

Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.

Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, Manfrini M, Galletti S.

Ann Oncol. 2003 Jul;14(7):1126-34.

PMID:
12853357
13.

Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease.

Harrison DJ, Schwartz CL.

Curr Treat Options Oncol. 2017 Apr;18(4):24. doi: 10.1007/s11864-017-0464-2. Review.

PMID:
28391422
14.

Mifamurtide for the treatment of nonmetastatic osteosarcoma.

Ando K, Mori K, Corradini N, Redini F, Heymann D.

Expert Opin Pharmacother. 2011 Feb;12(2):285-92. doi: 10.1517/14656566.2011.543129. Review.

15.

Role of ezrin in osteosarcoma metastasis.

Ren L, Khanna C.

Adv Exp Med Biol. 2014;804:181-201. doi: 10.1007/978-3-319-04843-7_10. Review.

PMID:
24924175
16.

Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.

Bacci G, Ferrari S, Ruggieri P, Biagini R, Fabbri N, Campanacci L, Bacchini P, Longhi A, Forni C, Bertoni F.

Acta Orthop Scand. 2001 Apr;72(2):167-72.

PMID:
11372948
17.

Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial.

Ferguson WS, Harris MB, Goorin AM, Gebhardt MC, Link MP, Shochat SJ, Siegal GP, Devidas M, Grier HE.

J Pediatr Hematol Oncol. 2001 Aug-Sep;23(6):340-8.

PMID:
11563767
18.

Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.

Gordon N, Kleinerman ES.

J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):189-96. doi: 10.1089/jamp.2009.0812. Review.

19.

Selected applications of methotrexate alone and in combination in osteosarcoma.

Pratt CB.

Cancer Treat Rep. 1981;65 Suppl 1:107-11.

PMID:
6976828
20.

Kissing pleural metastases from metastatic osteosarcoma of the lung.

Mori T, Yoshioka M, Iwatani K, Kobayashi H, Yoshimoto K, Nomori H.

Ann Thorac Cardiovasc Surg. 2006 Apr;12(2):129-32.

PMID:
16702936

Supplemental Content

Support Center